Evidence map›Paper›PMID 32672883›Full record

ArticleEMBO reports2020

The regulation of glucose and lipid homeostasis via PLTP as a mediator of BAT-liver communication.

Carlos H Sponton, Takashi Hosono, Junki Taura, Mark P Jedrychowski, Takeshi Yoneshiro, Qiang Wang, Makoto Takahashi, Yumi Matsui, Kenji Ikeda, Yasuo Oguri and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. A critical role forActa pharmaceutica Sinica. B · 2025
    Article
  9. Article
  10. Article
  11. Frontiers in cardiovascular medicine · 2025
    Article
  12. Review
  13. Maintenance of thermogenic adipose tissues despite loss of the H3K27 acetyltransferases p300 or CBP.American journal of physiology. Endocrinology and metabolism · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Cancers · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 2 countries.

Carlos H SpontonDiabetes Center, University of California, San Francisco, CA, USA.
Takashi HosonoDiabetes Center, University of California, San Francisco, CA, USA.
Junki TauraEnd-Organ Disease Laboratories, Daiichi-Sankyo Co., Ltd., Tokyo, Japan.
Mark P JedrychowskiDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Takeshi YoneshiroDiabetes Center, University of California, San Francisco, CA, USA.
Qiang WangDiabetes Center, University of California, San Francisco, CA, USA.
Makoto TakahashiDrug Metabolism & Pharmacokinetics Research Laboratories, Daiichi-Sankyo Co., Ltd., Tokyo, Japan.
Yumi MatsuiProtein Production Research Group, Biological Research Department, Daiichi-Sankyo RD Novare Co., Ltd., Tokyo, Japan.
Kenji IkedaDiabetes Center, University of California, San Francisco, CA, USA.
Yasuo OguriDiabetes Center, University of California, San Francisco, CA, USA.
Kazuki TajimaDiabetes Center, University of California, San Francisco, CA, USA.
Kosaku ShinodaDiabetes Center, University of California, San Francisco, CA, USA.
Rachana N PradhanDiabetes Center, University of California, San Francisco, CA, USA.
Yong ChenDiabetes Center, University of California, San Francisco, CA, USA.
Zachary BrownDiabetes Center, University of California, San Francisco, CA, USA.
Lindsay S RobertsDepartments of Chemistry, Molecular and Cell Biology, and Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA.
Carl C WardDepartments of Chemistry, Molecular and Cell Biology, and Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA.
Hiroki TaokaGraduate School of Media and Governance, Keio University, Kanagawa, Japan.
Yoko YokoyamaGraduate School of Media and Governance, Keio University, Kanagawa, Japan.
Mitsuhiro WatanabeGraduate School of Media and Governance, Keio University, Kanagawa, Japan.
Hiroshi KarasawaEnd-Organ Disease Laboratories, Daiichi-Sankyo Co., Ltd., Tokyo, Japan.
Daniel K NomuraDepartments of Chemistry, Molecular and Cell Biology, and Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA.
Shingo KajimuraDiabetes Center, University of California, San Francisco, CA, USA.ORCID 0000-0003-0672-5910
University of California, San Francisco · USDaiichi-Sankyo (Japan) · JPKeio University Shonan Fujisawa · JPUniversity of California, Berkeley · USHarvard University · US

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
ZIDOVUDINE &LAMIVUDINE &NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFM01RR001271 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$22.7M
UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
Molecular mechanisms of UCP1-independent pathways in metabolic healthR01DK097441 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Shingo Kajimura · 2012 to 2026
$5.9M
Molecular control of beige fat heterogeneityR01DK125281 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAJIMURA, SHINGO · 2020 to 2023
$1.9M
BAT-mediated inter-organ communication in energy homeostasisR01DK108822 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAJIMURA, SHINGO · 2016 to 2019
$1.4M
Edward Mallinckrodt, Jr. Foundation (EMF)Japan Society for the Promotion of Science London (JSPS London)Manpei Suzuki Diabetes FoundationNCRR NIH HHS M01 RR001271NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK098722NIDDK NIH HHS R01 DK097441NIDDK NIH HHS R01 DK108822NIDDK NIH HHS R01 DK125281Sao Paulo Research Foundation 2016/03682-3
6 · The paper itself

Abstract

While brown adipose tissue (BAT) is well-recognized for its ability to dissipate energy in the form of heat, recent studies suggest multifaced roles of BAT in the regulation of glucose and lipid homeostasis beyond stimulating thermogenesis. One of the functions involves interorgan communication with metabolic organs, such as the liver, through BAT-derived secretory factors, a.k.a., batokine. However, the identity and the roles of such mediators remain insufficiently understood. Here, we employed proteomics and transcriptomics in human thermogenic adipocytes and identified previously unappreciated batokines, including phospholipid transfer protein (PLTP). We found that increased circulating levels of PLTP, via systemic or BAT-specific overexpression, significantly improve glucose tolerance and insulin sensitivity, increased energy expenditure, and decrease the circulating levels of cholesterol, phospholipids, and sphingolipids. Such changes were accompanied by increased bile acids in the circulation, which in turn enhances glucose uptake and thermogenesis in BAT. Our data suggest that PLTP is a batokine that contributes to the regulation of systemic glucose and lipid homeostasis as a mediator of BAT-liver interorgan communication.

Indexed as

Adipose Tissue, BrownGlucoseEnergy MetabolismHomeostasisHumansLipidsLiverThermogenesisGlucoseLipidsbrown adipose tissueinterorgan communicationlipid homeostasis

Identifiers

PMID32672883
PMCPMC7507062
OpenAlexW3043760897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.